The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Antipsychotics, mood stabilisers, and risk of violent crime
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This aligns with previous findings of the reduction in violent crime associated with psychosis treatment (Fazel et al., 2014).”
From Unmet needs: analysing the Fixated Threat Assessment Centre’s fulfilment of the public health approach, and its value for violence prevention (2025) · cites this paper as Fazel et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Elbogen, E. B., & Johnson, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.537 · Cited by 868
Schizophrenia, substance abuse, and violent crime
Fazel, S. (2009) · JAMA · doi:10.1001/jama.2009.675 · Cited by 726
Medication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Self-citationThe population impact of severe mental illness on violent crime
Fazel, S., & Grann, M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1397 · Cited by 539
Self-citationTrends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217
Carbamazepine for schizophrenia
Leucht, S., Helfer, B., Dold, M., Kissling, W., & McGrath, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001258.pub3 · Cited by 82
Research works printed but not linked: 45
- Verdoux, 2009, Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies, Acta Psychiatr Scand, 121, 4, 10.1111/j.1600-0447.2009.01425.x · DOI
- Raschi, 2013, Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe, PloS One, 8, e81208, 10.1371/journal.pone.0081208 · DOI
- Ilyas, 2012, Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010, Br J Psychiatry, 200, 393, 10.1192/bjp.bp.111.104257 · DOI
- Ilyas, 2012, Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010, Br J Psychiatry, 200, 393, 10.1192/bjp.bp.111.104257 · DOI
- Paulose-Ram, 2007, Trends in psychotropic medication use among U.S. adults, Pharmacoepidemiol Drug Saf, 16, 560, 10.1002/pds.1367 · DOI
- Beynon, 2009, Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials, J Psychopharmacol, 23, 574, 10.1177/0269881108093885 · DOI
- Geddes, 2004, Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials, Am J Psychiatry, 161, 217, 10.1176/appi.ajp.161.2.217 · DOI · Paper page
- Nelson, 2009, Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials, Am J Psychiatry, 166, 980, 10.1176/appi.ajp.2009.09030312 · DOI · Paper page
- Mercer, 2009, Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms, J Pers Disord, 23, 156, 10.1521/pedi.2009.23.2.156 · DOI
- Saha, 2007, A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?, Arch Gen Psychiatry, 64, 1123, 10.1001/archpsyc.64.10.1123 · DOI · Paper page
- Topiwala, 2011, The pharmacological management of violence in schizophrenia: a structured review, Expert Rev Neurother, 11, 53, 10.1586/ern.10.180 · DOI
- Kooyman, 2007, Outcomes of public concern in schizophrenia, Br J Psychiatry, 191, s29, 10.1192/bjp.191.50.s29 · DOI
- Fazel, 2009, Schizophrenia and violence: systematic review and meta-analysis, PLoS Med, 6, e1000120, 10.1371/journal.pmed.1000120 · DOI
- Steadman, 1998, Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods, Arch Gen Psychiatry, 55, 393, 10.1001/archpsyc.55.5.393 · DOI
- Fazel, 2010, Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review, Arch Gen Psychiatry, 67, 931, 10.1001/archgenpsychiatry.2010.97 · DOI
- McGuire, 2008, A review of effective interventions for reducing aggression and violence, Philos Trans R Soc Lond B Biol Sci, 363, 2577, 10.1098/rstb.2008.0035 · DOI
- Huband, 2010, Antiepileptic drugs for treating recurrent aggression, Cochrane Database Syst Rev, 2
- 2011, Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology, J Psychopharmacol, 25, 567, 10.1177/0269881110391123 · DOI
- Arango, 2006, Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence, Eur Psychiatry, 21, 34, 10.1016/j.eurpsy.2005.07.006 · DOI
- Leucht, 2011, Oral versus depot antipsychotic drugs for schizophrenia—a critical systematic review and meta-analysis of randomised long-term trials, Schizophr Res, 127, 83, 10.1016/j.schres.2010.11.020 · DOI
- De Hert, 2010, Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study, Schizophr Res, 117, 68, 10.1016/j.schres.2009.12.029 · DOI
- Ludvigsson, 2009, The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research, Eur J Epidemiol, 24, 659, 10.1007/s10654-009-9350-y · DOI
- Wettermark, 2007, The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months, Pharmacoepidemiol Drug Saf, 16, 726, 10.1002/pds.1294 · DOI · Paper page
- Kyaga, 2012, Mental illness, suicide and creativity: 40-Year prospective total population study, J Psychiatric Res, 47, 83, 10.1016/j.jpsychires.2012.09.010 · DOI
- Ekholm, 2005, Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses, Nord J Psychiatry, 59, 457, 10.1080/08039480500360906 · DOI · Paper page
- Sellgren, 2011, Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden, Acta Psychiatr Scand, 124, 447, 10.1111/j.1600-0447.2011.01747.x · DOI
- Allison, 1996, Fixed-effects partial likelihood for repeated events, Sociol Methods Res, 25, 207, 10.1177/0049124196025002003 · DOI
- Jones, 2011, Efficacy of mood stabilisers in the treatment of impulsive or repetitive aggression: systematic review and meta-analysis, Br J Psychiatry, 198, 93, 10.1192/bjp.bp.110.083030 · DOI
- Frogley, 2012, A systematic review of the evidence of clozapine's anti-aggressive effects, Int J Neuropsychopharmacol, 15, 1, 10.1017/S146114571100201X · DOI
- Hockenhull, 2012, A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour: update 2002–8, Health Technol Assess, 16, 1, 10.3310/hta16030 · DOI
- Schwarz, 2008, Valproate for schizophrenia, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD004028.pub3 · DOI
- Dove, 2012, Medications for adolescents and young adults with autism spectrum disorders: a systematic review, Pediatrics, 130, 717, 10.1542/peds.2012-0683 · DOI · Paper page
- Loy, 2012, Atypical antipsychotics for disruptive behaviour disorders in children and youths, Cochrane Database Syst Rev, 9, 10.1002/14651858.CD008559.pub2 · DOI
- Pringsheim, 2012, Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review, Can J Psychiatry, 57, 722, 10.1177/070674371205701203 · DOI
- Swanson, 2008, Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia, Br J Psychiatry, 193, 37, 10.1192/bjp.bp.107.042630 · DOI
- Kishimoto, 2014, Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials, Schizophr Bull, 40, 192, 10.1093/schbul/sbs150 · DOI
- Huband, 2010, Antiepileptic drugs for treating recurrent aggression, Cochrane Database Syst Rev, 2
- Jones, 2011, Efficacy of mood stabilisers in the treatment of impulsive or repetitive aggression: systematic review and meta-analysis, Br J Psychiatry, 198, 93, 10.1192/bjp.bp.110.083030 · DOI
- Baldwin, 2007, Off-label prescribing in psychiatric practice, Adv Psychiatr Treat, 13, 414, 10.1192/apt.bp.107.004184 · DOI
- Haw, 2005, A survey of the off-label use of mood stabilizers in a large psychiatric hospital, J Psychopharmacol, 19, 402, 10.1177/0269881105053307 · DOI
- Citrome, 2007, The psychopharmacology of violence with emphasis on schizophrenia, part 2: long-term treatment, J Clin Psychiatry, 68, 331, 10.4088/JCP.v68n0220 · DOI
- Citrome, 2002, Datapoints: use of mood stabilizers among patients with schizophrenia, 1994–2001, Psychiatric Services, 53, 1212, 10.1176/appi.ps.53.10.1212 · DOI
- Citrome, 2010, Datapoints: depot antipsychotic use in New York state hospitals, 1994 to 2009, Psychiatric Services, 61, 9, 10.1176/ps.2010.61.1.9 · DOI
- Coid, 2013, The relationship between delusions and violence: findings from the East London first episode psychosis study, JAMA Psychiatry, 70, 465, 10.1001/jamapsychiatry.2013.12 · DOI
- Pamer, 2010, Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions, Pharmacoepidemiol Drug Saf, 19, 158, 10.1002/pds.1886 · DOI
Cited by
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Violence against women and mental health
Oram, S., Khalifeh, H., & Howard, L. M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30261-9 · Cited by 474
Racial and Ethnic Disparities in Mental Health Care for Children and Young Adults: A National Study
Marrast, L., Himmelstein, D. U., & Woolhandler, S. (2016) · International Journal of Health Services · doi:10.1177/0020731416662736 · Cited by 257
Seaward, A., Marchment, Z., Wilson, S., Elfituri, S., Farnham, F., Plumb, T., Rose, K., Taylor, A., Corner, E., & Gill, P. (2025) · Psychology, Crime & Law · doi:10.1080/1068316x.2025.2581795 · Cited by 1
Metadata
- Authors
- Fazel, S., Zetterqvist, J., Larsson, H., Långström, N., & Lichtenstein, P.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 384
- Issue
- 9949
- Pages
- 1206-1214
- ISSN
- 0140-6736
- Cited by
- 207
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.